ANLN and esophageal squamous cell carcinoma: Proteomic analysis showed that F806 mainly inhibited ESCC by reducing the expression of mitosis-related proteins, including ANLN (Supplementary Fig. S3A–E and Supplementary Data 1, 3, 4).